Patent Reform Provision Extending Angiomax Patent Would Cost $1 Bil. – CBO
Executive Summary
The Medicines Company scored a lobbying victory when a provision was tucked into patent reform legislation that would authorize the Patent and Trademark Office to accept late applications
You may also be interested in...
Patent Reform Legislation Introduced; Damages, Inequitable Conduct In Flux
Senate language from the patent reform debate in the last Congress will be the starting point this year for negotiations on how to calculate a reasonable royalty for patent infringement
Patent Reform Legislation Introduced; Damages, Inequitable Conduct In Flux
Senate language from the patent reform debate in the last Congress will be the starting point this year for negotiations on how to calculate a reasonable royalty for patent infringement
Kyl’s Patent Reform Bill Gains Acceptance From Drug And Biotech Industries
While the Senate deadlocked on patent reform legislation this year, the stage has been set to take up the battle again in the next Congress